
    
      Specific Aims:

      Aim 1: To evaluate the feasibility and acceptability of proactive psychiatry consultation and
      case management among individuals with SMI treated at the MGH Cancer Center and their
      oncology clinicians.

      Aim 2: To describe the rates of receipt of stage-appropriate cancer treatment and patterns of
      healthcare utilization in patients with SMI and cancer who are receiving the intervention

      Aim 3: To explore patterns of change in psychiatric symptoms, quality of life, illness
      understanding, and alliance with the oncology clinician in patients with SMI and a recent
      cancer diagnosis who are receiving the intervention.
    
  